Study Details

General Information

Cephalon Chronic Pain 3056

A Randomized, Double-Blind, Active-Controlled Crossover Study to Evaluate the Efficacy and Safety of Fentanyl Buccal Tablets Compares With Immediate-Release Oxycodone for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Pain, Followed by a 12-Week Open-Label Extension to Evaluate the Impact of Fentanyl Buccal Tablets on Patients Outcomes.

ProtocolC25608/3056/BP/US
IdentifierC25608/3056/BP/US
UIDae2785e7-2777-4464-8ff9-4c62185eb647
StatusDone - Archived
Phase3B
CategoryPain
Launch Year2009
NCT Number-
Created2012-05-04 16:34
Last Updated2012-05-04 16:34

Description

No description provided.

Comment

No comment.

Target Dates

NameDateRequired
Enrollment Closed2009-02-20No
Enrollment Open2009-02-19No
First Patient First VisitNo
Site Initiation Mtg.No
PI Meeting StartNo
PI Meeting EndNo
PI Meeting ArrivalNo
PI Meeting DepartureNo
Closeout Date2010-02-02No
Final PatientVisitNo
PreStudy Selection VisitNo
Target Date 12No
Target Date 13No
Target Date 14No

Leadership

RoleStaffLoginRequired
PrincipalMohaupt, StephenSMohauptNo
Recruiter-No
Coordinator-No
Regulatory-No

Custom Fields

No custom fields.

Sponsor & Organization

SponsorCephalon
DivisionCephalon
TeamCephalon
Managing SiteCatalina Research Institute, LLC
Organization

Contacts

IRB Ref
CRO
CRO Ref
Correspondence0

Opportunity

Probability0
Comment
Status ColorGainsboro
Currency-
Mayra Sibley

2 Hours

Hi there, I'm Jesse and you?
You

3 minutes

My name is Anne Clarc.
Mayra Sibley

40 seconds

Nice to meet you Anne.
How can i help you?